Dr. Alexander Bershadskiy, MD

  • Staten Island, NY
  • Hematologist and oncologist
NPI1407016116PAC ID5395061303
Medicare services, 2024
1,899
Medicare patients, 2024
405
Part D claims, 2024
1,504
Publications
12
Clinical trials
7
Practice address
475 Seaview Ave, Staten Island, NY 10305
Practice phone
Call (718) 226-4502
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Staten Island University Hospital - North Campus

Staten Island, New York

See all 5 affiliations

Find Dr. Bershadskiy's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Alexander Bershadskiy is a hematologist and oncologist in Staten Island, New York

Dr. Bershadskiy practices at Staten Island University Hospital - North Campus in Staten Island, New York.

Dr. Bershadskiy's NPI, 1407016116, was assigned on June 16, 2008. Dr. Bershadskiy holds New York license 263136.

NPI and contact details
Medicare PAC ID
5395061303
NPI enumeration date
June 16, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(718) 226-4502
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
44
Medical school graduation
2008

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Alexander Bershadskiy practices at Staten Island University Hospital - North Campus in Staten Island, New York

Dr. Bershadskiy's primary practice is Staten Island University Hospital - North Campus, at 475 Seaview Ave, Staten Island, NY 10305 in Richmond County. The practice phone is (718) 226-4502.

  • Staten Island University Hospital - North Campus
    475 Seaview Ave, Staten Island, NY 10305 · Richmond CountyPhone(718) 226-4502

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Alexander Bershadskiy is affiliated with 2 sites of care and 3 medical groups

Dr. Bershadskiy's primary practice is Staten Island University Hospital - North Campus in Staten Island, New York. Dr. Bershadskiy is also affiliated with Staten Island University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Bershadskiy to 2 more medical groups, each named with a free account.

See all 5 affiliations for Dr. Bershadskiy

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Alexander Bershadskiy's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bershadskiy practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Staten Island University Hospital - North CampusAvailable with a free account
+1 more site and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Bershadskiy practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Alexander Bershadskiy is one of 996 hematologists and oncologists in New York

Hematology and oncology is Dr. Bershadskiy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bershadskiy is licensed in New York.

Specialties and state licenses

  • Hematology and oncology, New YorkPrimaryLicense 263136 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Bershadskiy

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Alexander Bershadskiy billed Medicare for 1,899 services in 2024

CMS data shows 1,899 Medicare services from Dr. Bershadskiy across 10 procedure codes in 2024, for 405 Medicare patients. Medicare paid $110,619 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 20241,899
Medicare patients405
Paid by Medicare$110,619
Procedure codes10

Dr. Bershadskiy's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 9162024: 1,18429%
Other services
2023: 02024: 715

Dr. Bershadskiy compared with the New York median for hematologists and oncologists, 2024

  • Dr. Bershadskiy
  • New York median
Medicare services
1,899vs 6682.8 times
Medicare patients
405vs 21093% above
Part D claims
1,079vs 2584.2 times

Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.

Dr. Bershadskiy's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Bershadskiy

Need commercial claims for Dr. Bershadskiy?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bershadskiy and other hematologists and oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Alexander Bershadskiy treated 405 Medicare patients in 2024, average age 75

CMS counts 405 Medicare patients who saw Dr. Bershadskiy in 2024. The largest group is 75 to 84, with 178 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bershadskiy's median patient age at 75, with 47% women.

Medicare patients, 2024405
Average age75
Average risk score2.60
Also on Medicaid29%

Dr. Bershadskiy's Medicare patients by age, 2024

Dr. Bershadskiy's Medicare patients by sex, 2024

  • Women19047%
  • Men21553%

Chronic conditions among Dr. Bershadskiy's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis57%
  4. Diabetes55%
  5. Ischemic heart disease55%
  6. Cancer52%
  7. Chronic kidney disease37%
  8. Heart failure34%

Share of Medicare patients with each condition. A patient can have several.

Dr. Bershadskiy's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 75

Patient panel by sex, all payers

  • Women47%
  • Men50%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Alexander Bershadskiy wrote 1,504 Medicare Part D claims in 2024

In 2024, Dr. Bershadskiy wrote 1,504 Medicare Part D claims for 209 patients. 66% of them were for generic drugs. CMS names the drug for 1,079 of them, across 34 drugs with 11 or more claims each, at $3,531,216 in total drug cost. In 2023, CMS named 977 claims across 35 drugs.

Part D claims, 20241,504
Drugs named by CMS34
Total drug cost$3.5M
Part D patients209

Dr. Bershadskiy's Part D claims by kind of drug, 2024

  • Generic989 claims66%
  • Brand-name and other515 claims34%

Dr. Bershadskiy's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Bershadskiy's Part D claims, 2024

  • Opioids5%82 of 1,504 claims
  • Antibiotics2%32 of 1,504 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 9772024: 1,07910%

Drugs named by CMS: 34 in 2024, 35 in 2023.

See all prescribing by Dr. Bershadskiy

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Alexander Bershadskiy scored 79 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Bershadskiy for performance year 2024, reported as part of a group. Dr. Bershadskiy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bershadskiy as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Bershadskiy's MIPS scores, performance year 2024

  • 79of 100Final score
  • 57.9of 100Quality
  • 77of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 80of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Bershadskiy by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Alexander Bershadskiy has 12 publications on record

Dmand AI links 12 papers to Dr. Bershadskiy, published from 2012 to 2024. 2021 was the busiest year, with 2. Dr. Bershadskiy has published most often in Cureus. Dr. Bershadskiy's most frequent co-authors are Kira MacDougall, MD, Mohammad Abureesh, MD and Laurence Aoun.

Papers12
Years published2012 to 2024

Dr. Bershadskiy's papers by year, 2012 to 2024

Dr. Bershadskiy's most frequent co-authors

Recent publications by Dr. Bershadskiy

See all 12 publications and co-authors

See who Dr. Bershadskiy researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bershadskiy works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Alexander Bershadskiy has worked on 7 clinical trials

Dmand AI links Dr. Bershadskiy to 7 clinical trials, 4 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Rectal Neoplasms. National Cancer Institute (NCI) sponsors the most, 5.

Clinical trials with Dr. Bershadskiy by phase

  1. NonePhase 1: no trials
  2. 2Phase 2: 2 trials
  3. 4Phase 3: 4 trials
  4. NonePhase 4: no trials

Conditions in Dr. Bershadskiy's trials

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Bronchogenic
  • Rectal Neoplasms
  • Rectal Diseases

Investigators on the most trials with Dr. Bershadskiy

Recent clinical trials with Dr. Bershadskiy

See all 7 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Alexander Bershadskiy received $104 in industry payments from 2016 to 2022

CMS Open Payments shows 7 general payments to Dr. Bershadskiy from 5 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 89% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $29.

General payments to Dr. Bershadskiy by program year, 2016 to 2022

General payments to Dr. Bershadskiy by kind, 2016 to 2022

$104in total
  • Food and beverage$9289%
  • Education$1211%

Companies that paid Dr. Bershadskiy the most, 2016 to 2022

Share is of all general payments to this clinician.

See all payments to Dr. Bershadskiy

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Alexander Bershadskiy's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Alexander Bershadskiy

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Alexander Bershadskiy's NPI number?

Dr. Alexander Bershadskiy's NPI number is 1407016116. It was assigned on June 16, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Alexander Bershadskiy?

Dr. Alexander Bershadskiy is a hematologist and oncologist in Staten Island, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Alexander Bershadskiy practice?

Dr. Bershadskiy practices at 475 Seaview Ave, Staten Island, NY 10305. Dr. Bershadskiy's primary practice is Staten Island University Hospital - North Campus in Staten Island, New York. Dmand AI also links Dr. Bershadskiy to 2 medical groups.

What is Dr. Alexander Bershadskiy's office phone number?

The practice phone on file for Dr. Bershadskiy is (718) 226-4502.

What is Dr. Alexander Bershadskiy's medical license number?

Dr. Bershadskiy holds New York license 263136.

Which hospitals is Dr. Alexander Bershadskiy affiliated with?

Dr. Bershadskiy is affiliated with Staten Island University Hospital.

What medical group is Dr. Alexander Bershadskiy part of?

Dr. Bershadskiy is linked to Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI links Dr. Bershadskiy to 2 more medical groups.

Does Dr. Alexander Bershadskiy accept Medicare?

Yes. CMS data shows Dr. Bershadskiy billed Medicare for 1,899 services in 2024, and Dr. Bershadskiy accepts Medicare assignment.

Does Dr. Alexander Bershadskiy offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Bershadskiy as offering telehealth services.

What is Dr. Alexander Bershadskiy's MIPS score?

Dr. Bershadskiy's MIPS final score for performance year 2024 is 79 out of 100, reported as part of a group.

Show 7 more questionsShow fewer questions

How many Medicare patients does Dr. Alexander Bershadskiy see?

CMS counts 405 Medicare patients who saw Dr. Bershadskiy in 2024, with an average age of 75.

What services does Dr. Alexander Bershadskiy bill to Medicare?

In 2024, Dr. Bershadskiy's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and hospital inpatient care (99232).

What drugs does Dr. Alexander Bershadskiy prescribe most?

In 2024 Medicare Part D data, Dr. Bershadskiy's most prescribed drugs by claims were Abiraterone Acetate, Prednisone and Ondansetron HCl.

Has Dr. Alexander Bershadskiy received payments from drug or device companies?

CMS Open Payments shows $104 in general payments to Dr. Bershadskiy from 5 companies from 2016 to 2022. The largest total came from Bayer HealthCare Pharmaceuticals Inc.

How long has Dr. Alexander Bershadskiy been practicing?

Dr. Bershadskiy graduated from medical school in 2008, 18 years ago.

Does Dr. Alexander Bershadskiy do research?

Dmand AI links 12 publications to Dr. Bershadskiy, published from 2012 to 2024. Dr. Bershadskiy has worked on 7 clinical trials.

Who does Dr. Alexander Bershadskiy publish with?

Dr. Bershadskiy's most frequent co-authors are Kira MacDougall, MD (2 shared papers), Mohammad Abureesh, MD (1 shared paper) and Laurence Aoun (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)